DeepMed Research

HACKENSACK MERIDIAN HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 2016-01-01

Employees: -

Market Cap: -

Website: https://www.hackensackmeridianhealth.org/

Clinical Trials

Quit & Fit 2.0: Feasibility and Usability Testing

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Behavioral: Culturally-tailored Tobacco Treatment
Behavioral: Culturally-tailored Content Newsletters
Behavioral: Control Preference Scale
Behavioral: Active Content Newsletter or Passive Content Newsletter

First Posted Date: 2023-05-30

Last Posted Date: 2024-10-17

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 22

Registration Number: NCT05878990

Locations: 🇺🇸
Hackensack Meridian Health - Center for Discovery and Innovation, Nutley, New Jersey, United States

Continuous Glucose Monitoring and Diabetes

Not Applicable

Terminated

Conditions: Diabetes

Interventions: Other: Continuous Glucose Monitoring and Education Support

First Posted Date: 2023-05-03

Last Posted Date: 2025-01-10

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 10

Registration Number: NCT05840250

Locations: 🇺🇸
Hackensack Univeristy Medical Center, Hackensack, New Jersey, United States

The INSPIRE-Lung Study

Not Applicable

Recruiting

Conditions: Lung Cancer

Interventions: Behavioral: LungTalk
Behavioral: Non-tailored intervention - Standard of practice

First Posted Date: 2023-04-21

Last Posted Date: 2025-01-08

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 500

Registration Number: NCT05824273

Locations: 🇺🇸
Hackensack Meridian Health - Center for Discovery and Innovation, Nutley, New Jersey, United States

Fluoroquinolone Resistance Prevalence Study

Terminated

Conditions: Multiple Myeloma

First Posted Date: 2023-04-21

Last Posted Date: 2025-05-13

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 105

Registration Number: NCT05824689

Locations: 🇺🇸
John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, United States
🇺🇸
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, United States

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

Early Phase 1

Recruiting

Conditions: Nausea
Pain

Interventions: Drug: Prophylactic use of ibuprofen and ondansetron post misoprostol administration
Drug: Use of ibuprofen and ondansetron at symptom onset post misoprostol administration

First Posted Date: 2023-04-19

Last Posted Date: 2025-01-10

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 168

Registration Number: NCT05819619

Locations: 🇺🇸
Antonia Oladipo, Hackensack, New Jersey, United States

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Phase 4

Active, not recruiting

Conditions: Flank Pain
Emergencies
Analgesia
Renal Colic

Interventions: Drug: Ketorolac

First Posted Date: 2023-03-20

Last Posted Date: 2025-04-30

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 62

Registration Number: NCT05776953

Locations: 🇺🇸
Hackensack Univarsity medical Center, Hackensack, New Jersey, United States

Iscador® P (Mistletoe) Immunotherapy for Recurrent Osteogenic Sarcoma

Phase 2

Recruiting

Conditions: Osteogenic Sarcoma Recurrent

Interventions: Drug: Iscador*P

First Posted Date: 2023-02-13

Last Posted Date: 2024-11-14

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 32

Registration Number: NCT05726383

Locations: 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
M.D. Anderson Children's Cancer Hospital, Houston, Texas, United States

Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma

Not Applicable

Terminated

Conditions: Anxiety Disorder
Bipolar Disorder
Mental Health Issues
Depressive
Schizophrenia Spectrum and Other Psychotic Disorders

Interventions: Behavioral: Group Music Therapy Advocacy Recording Intervention (MTAR)

First Posted Date: 2023-02-10

Last Posted Date: 2024-07-05

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 7

Registration Number: NCT05723328

Locations: 🇺🇸
Carrier Clinic, Belle Mead, New Jersey, United States

Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With Immunotherapy

Phase 2

Recruiting

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Drug: Carboplatin
Drug: Paclitaxel
Drug: Pemetrexed

First Posted Date: 2023-02-06

Last Posted Date: 2025-01-20

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 108

Registration Number: NCT05715229

Locations: 🇺🇸
John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, New Jersey, United States
🇺🇸
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, United States
🇺🇸
Jersey Shore University Medical Center, Neptune, New Jersey, United States

Arrythmia Burden in Cardiac Contractility Modulation (CCM)

Terminated

Conditions: Atrial Fibrillation
Arrythmia

Interventions: Device: Impulse Dynamics Optimizer Device

First Posted Date: 2023-01-30

Last Posted Date: 2024-08-19

Lead Sponsor: Hackensack Meridian Health

Target Recruit Count: 2

Registration Number: NCT05704426

Locations: 🇺🇸
Hackensack Univeristy Medical Center, Hackensack, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy